La Roche RWE Expert Discusses Industry Trends, Including Adoption by HTAs

June 3, 2021

Sreeram Ramagopalan shared his thoughts on how health technology assessments (HTAs) are reacting to an increase in real world evidence (RWE). He notes a range of guidelines and acceptance of RWE by different HTAs.

“Read highlights from the latest instalment of Sreeram Ramagopalan’s (F. Hoffmann-La Roche, Basel, Switzerland) industry news round-up, which discusses some of the latest developments in real-world evidence (RWE) as it relates to health technology assessment (HTA) and acceptance of RWE by HTA agencies, and is published bi-monthly in our partner journal, the Journal of Comparative Effectiveness Research. The full update for February–March 2021, ‘R WE ready for reimbursement?” Read more here.